| Literature DB >> 24341633 |
Guo Min Liu, Ya Jun Wang, Dong Sheng Wang, Qin-Yi Liu1.
Abstract
BACKGROUND: This study aims to compare the perioperative parameters and clinical results between microendoscopy laminoforaminotomy (MELF) and cervical arthroplasty (CA) in the treatment of one-level cervical spondylotic radiculopathy in a retrospective study.Entities:
Mesh:
Year: 2013 PMID: 24341633 PMCID: PMC3868414 DOI: 10.1186/1749-799X-8-48
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Preoperative patient demographics
| Total patients enrolled | 45 | 52 |
| Female | 26 (57.8%) | 18 (34.6%) |
| Male | 19 (42.2%) | 34 (65.4%) |
| Age (years) | 47.6 ± 7.9 (range 31–66) | 43.0 ± 10.0 (range 24–62) |
| Physical characteristics | | |
| Height (in.) | 67.7 ± 3.9 | 68.3 ± 4.6 |
| Weight (lb) | 172.5 ± 40.0 | 188.1 ± 42.7 |
| Symptom scores | | |
| Arm pain VAS | 69.1 ± 13.7 | 67.3 ± 13.3 |
| Neck pain VAS | 68.7 ± 11.3 | 66.2 ± 12.4 |
| NDI | 45.9 ± 10.1 | 45.5 ± 13.0 |
| SF-36 | 34.3 ± 5.8 | 35.1 ± 5.3 |
| Surgery level | | |
| C3/4 | 0 | 0 |
| C4/5 | 2 (4.4%) | 2 (3.9%) |
| C5/6 | 26 (57.8%) | 15 (28.8%) |
| C6/7 | 17 (37.8%) | 30 (57.7%) |
| C7/T1 | 0 | 5 (9.6%) |
Data are stated as mean ± standard deviation or number (percentage).
Perioperative parameters (mean ± standard deviation, CA vs. MELF)
| Surgical time (min) | 95.1 ± 10.6 | 24.0 ± 5.4* |
| EBL (ml) | 75.8 ± 15.7 | 31.8 ± 11.6* |
| X-ray exposure (s) | 60.3 ± 8.5 | 12.1 ± 1.4* |
| Hospital stay (day) | 1.1 ± 0.39 | 0.13 ± 0.13* |
*P < 0.01 in Student t test indicates statistically significant difference compared with the CA group.
Follow-up parameters (mean ± standard deviation, CA vs. MELF)
| NDI | | | | | | |
| CA | 46.1 ± 7.1* | 29.0 ± 5.5 | 23.1 ± 4.1 | 22.0 ± 3.5 | 21.3 ± 3.6 | 11.1 ± 2.5 |
| MELF | 45.1 ± 8.1* | 31.0 ± 5.7 | 20.3 ± 4.1 | 20.1 ± 4.5 | 18.1 ± 3.1 | 10.2 ± 3.5 |
| Neck pain VAS | | | | | | |
| CA | 70.4 ± 8.4* | 31.6 ± 11.6 | 25.4 ± 7.2 | 23.6 ± 7.6 | 20.0 ± 6.5 | 18.1 ± 6.1 |
| MELF | 68.6 ± 10.4* | 29.6 ± 7.6 | 24.4 ± 6.8 | 23.0 ± 7.4 | 21.1 ± 6.9 | 16.7 ± 6.4 |
| Arm pain VAS | | | | | | |
| CA | 72.2 ± 7.4* | 18.0 ± 5.2 | 19.1 ± 6.1 | 20.0 ± 4.5 | 18.1 ± 3.6 | 12.1 ± 2.7 |
| MELF | 71.3 ± 7.6* | 18.0 ± 4.6 | 17.2 ± 5.8 | 16.4 ± 3.8 | 15.2 ± 3.4 | 12.2 ± 2.2 |
| SF-36 PCS | | | | | | |
| CA | 33.3 ± 3.6* | 40.0 ± 3.8 | 47.3 ± 4.6 | 48.1 ± 4.9 | 49.3 ± 5.6 | 52.2 ± 5.4 |
| MELF | 35.1 ± 4.6* | 38.8 ± 4.4 | 44.7 ± 4.9 | 50.0 ± 5.5 | 49.1 ± 5.1 | 51.5 ± 5.2 |
| SF-36 MCS | | | | | | |
| CA | 46.2 ± 3.6* | 53.0 ± 4.4 | 55.1 ± 4.6 | 54.0 ± 5.4 | 55.3 ± 5.6 | 54.1 ± 5.3 |
| MELF | 47.1 ± 3.9* | 55.3 ± 3.1 | 53.3 ± 4.3 | 53.4 ± 5.3 | 54.2 ± 5.3 | 54.3 ± 5.1 |
*P < 0.01 in Student t test indicates statistically significant difference compared with any other time point in the same group, based on the NDI score for functional disability and neurogenic symptoms, VAS for neck and arm pain, and SF-36 score for PCS and MCS. No significant difference was observed between MELF and CA at 1.5, 3, and 6 months, and at 1- and 2-year follow-ups (P > 0.05 in Student t test).